TrialJournal of diabetes research2015

Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus.

Bindu Chamarthi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.